I can't see if this threads been here before but my night time scrolling last night went down a great rabbit hole. I'm asthmatic and have had some very bad chest infections (affecting mobility, chest scans, weird radioactive ones etc) and as I work with people develop a bit of a fear of colds.
Anyway as someone who was morbidly obese I'm on Mounjaro currently - I found it reduced inflammation in my body within weeks and I was able to walk...
But the asthma link I've only just discovered. It seems that Glp-1s affect receptors in the lungs, and helps reduce inflammation. So benefit asthmatic not just through the weight loss.
https://pmc.ncbi.nlm.nih.gov/articles/PMC9727043/ This is a NiCE link from 2022
"Plain Language Summary
Obesity is a common issue and a comorbidity that negatively impacts asthma outcomes. Weight loss can improve asthma outcomes, and evider shows that a particular type of therapy currently indicated for diabetes that assists in weight loss and targets receptors that are abundant in the lungs will outperform other therapies. GLP-1- receptor agonists may particularly help overweight patients who have asthma to control the disease as best as possible and prevent exacerbations. "
This is so exciting.
And more recently - from Aberdeen summer this year" https://www.abdn.ac.uk/news/24561/ "
Which suggests a protective effect even without weightloss (it says 0.9kg over a year - I have no idea how anyone is on glp1s and only losing 1kg??? But that's not their point...!)
(I'm both excited at yet another benefit Glp1s are giving me whilst terrified in a Black Mirror eque fear that I need to pay to keep this level of health.)